| Help us to promote this site! Link to us |
|
|
|
||||
| Email This Page to Friend | |||||
|
Lung Cancer News
|
||||
|
by AP 2 Sep 2010 at 3:01am Allergan Inc., the maker of wrinkle-smoothing Botox, has agreed to pay $600 million to settle a yearslong federal investigation into its marketing of the top-selling, botulin-based drug. by Reuters 2 Sep 2010 at 6:20am A study funded by Abbott Laboratories offered more detailed evidence that its weight-loss drug Meridia increases heart risks, prompting renewed calls by consumer advocates and others to pull the drug from the market. by HealthDay 2 Sep 2010 at 8:03am THURSDAY, Sept. 2 (HealthDay News) -- Many Americans have skewed perceptions when it comes to their weight, often believing they are lighter than they actually are, even when the scales are shouting otherwise, a new poll finds. by Reuters 2 Sep 2010 at 6:19am While staying mentally active in old age has been linked to a delayed onset of dementia, seniors who engage in such brain "exercise" may actually have a faster rate of decline once Alzheimer's is diagnosed, researchers reported Wedne... by AFP 2 Sep 2010 at 4:27am The chief of the UNAIDS agency said Thursday that global contributions to fighting the disease are dropping off for the first time in 15 years amid tough economic times. by Reuters 2 Sep 2010 at 11:21am Companies are cutting healthcare costs further amid a continuing sour economy, scaling back benefits and shifting a greater share of the expense to employees. by Reuters 2 Sep 2010 at 10:35am The estrogen-like compounds found in soy could help postmenopausal women get a better night's sleep, according to a small study. by Reuters 2 Sep 2010 at 12:19pm Women who start menstruating early may be at increased risk of asthma and poor lung function, new research shows. by Reuters 2 Sep 2010 at 2:33pm A cell phone text message -- and the buzz or beep that signals its arrival -- may not help a woman remember to pop her birth control pill, a new study suggests. by AFP 2 Sep 2010 at 1:05pm Researchers have discovered a promising new malaria drug with the potential to treat resistant strains of the deadly disease in a single dose, according to a study published Thursday in the journal Science. by Reuters 2 Sep 2010 at 2:38pm Pakistan's displaced flood victims say a lack of clean water and high temperatures are causing illnesses sweeping through relief camps with children most at risk. by Reuters 2 Sep 2010 at 1:54pm An experimental Novartis drug can clear malaria infection in mice with a single dose and scientists say it shows promise as a possible future treatment for one of the world's major killer diseases. by AFP 2 Sep 2010 at 2:16pm A groundbreaking new test can accurately diagnose drug-resistant tuberculosis (TB) in as little as two hours, researchers wrote in a study published Thursday in the New England Journal of Medicine. by Reuters 2 Sep 2010 at 1:46pm When it comes to changing health behaviors, it takes more than a far-flung network of friends on Facebook egging you on. It takes a jostling herd, U.S. researchers said on Thursday. by Reuters 2 Sep 2010 at 2:30pm A study funded by Abbott Laboratories offered more detailed evidence that its weight-loss drug Meridia increases heart risks, prompting renewed calls by consumer advocates and others to pull the drug from the market. 2 Sep 2010 at 7:24pm The American Lung Association is offering a free-of-charge, online caregiving coordination service called "My Fighting for Air Community" to support individuals affected by acute and chronic lungA diseases. 2 Sep 2010 at 3:24pm " After a two-year battle with lung cancer, John Regis passed away on July 28th, 2010. 2 Sep 2010 at 12:14pm Whether tumor size and stage distribution are correlated remains controversial. The objective is to assess the relationship between tumor size and disease stage distribution in non-small cell lung cancer . 2 Sep 2010 at 8:10am A patient receives chemotherapy treatment in a file photo. The Kingston-based researchers learned that four stages of chemotherapy after an operation increases survival rates in the "real world" which was identical to the 2004 investigation, said Christopher Booth of the Queen's Cancer Research Institute and lead author of the study. 2 Sep 2010 at 6:05am Prostate cancer is a significant public health concern and cause of morbidity among American men. 2 Sep 2010 at 1:55am The Vancouver Park Board has voted unanimously to ban smoking in city parks and on all city beaches, including here at Kitsilano Beach where cigarette butts litter the sand. 2 Sep 2010 at 12:51am You've read our thoughts on the Centers for Disease Control's effort to ban smoking in films and TV, so we thought we'd check in with Emmy nominee and lung cancer survivor Kathryn Joosten to get her sassy view on the matter. 1 Sep 2010 at 8:46pm In case you were wondering about the status of breast cancer, the following statistics were provided by the Northeast Ohio affiliate of Komen for the Cure . 1 Sep 2010 at 6:46pm A popular drug that is used by millions of diabetics around the world significantly decreases tobacco-induced lung tumors in mice, a study published Wednesday found. 1 Sep 2010 at 2:41pm Metformin, a drug commonly used to treat type 2 diabetes, shows potential in the prevention of tobacco-induced lung tumors, according to early research conducted at the National Cancer Institute . 1 Sep 2010 at 1:42pm There are millions of lung cancer patients around the world, and lung cancer survival rate without treatment is very low indeed. 1 Sep 2010 at 1:42pm Eating vegetables may help ward off lung cancer. A new study finds the key is a variety of vegetables, not the quantity. 1 Sep 2010 at 1:42pm The stage 3 lung cancer survival rate depends on the treatment and the physical condition of the patient, however the average stage 3 lung cancer survival rates range from 7 to 17 percent. 1 Sep 2010 at 11:42am People who consume a variety of vegetables tend to have a lower risk of developing lung cancer compared to those who don't, according to a study published in the medical journal Cancer Epidemiology, Biomarkers & Prevention , a publication of the American Association for Cancer Research. 1 Sep 2010 at 11:42am Washington, Sept 1 : A diverse diet of fruits and vegetables may decrease the risk of lung cancer - especially if you smoke, says a new study. |
3 Jun 2009 at 3:54am |
2 Sep 2010 at 8:00am Two studies reveal that smokers may have a significantly lower risk of developing lung cancer and colorectal cancer with the drug metformin, which is commonly prescribed for diabetes type 2 treatment, the medical journal Cancer Prevention Research informs... 2 Sep 2010 at 7:00am The American Lung Association is offering a free-of-charge, online caregiving coordination service called "My Fighting for Air Community" to support individuals affected by acute and chronic lung diseases... 2 Sep 2010 at 5:00am Metformin, a drug commonly used to treat type 2 diabetes, shows potential in the prevention of tobacco-induced lung tumors, according to early research conducted at the National Cancer Institute (NCI). Results of this study will be published in the September issue of Cancer Prevention Research, a journal of the American Association for Cancer Research. Scott Lippman, M.D... 1 Sep 2010 at 8:00am People who consume a variety of vegetables tend to have a lower risk of developing lung cancer compared to those who don't, according to a study published in the medical journal Cancer Epidemiology, Biomarkers & Prevention, a publication of the American Association for Cancer Research... 1 Sep 2010 at 5:00am Adding a variety of vegetables to one's diet may help decrease the chance of getting lung cancer, and adding a variety of fruits and vegetables may decrease the risk of squamous cell lung cancer, especially among smokers. Study results are published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research... 31 Aug 2010 at 2:00am Maybe you worshipped the sun in your youth or weren't as meticulous as you should have been with sunscreen. If so, take heart: Scientists at The University of Texas Health Science Center San Antonio are finding that certain plant substances, when given in combinations, may suppress damage that can cause skin cancer... 27 Aug 2010 at 7:00am The American Lung Association is encouraging patients with lung cancer to take charge of their diagnosis and learn about clinical trials through the Lung Cancer Clinical Trial Call to Action campaign. This service provides personalized education to quickly identify trial options that match each patient's specific diagnosis, stage, and treatment history... 27 Aug 2010 at 4:00am Second-hand smoke is associated with a number of diseases and conditions, including cancer, heart disease, and emphysema. It is an irritant to lung tissue and blood vessels, but the processes through which the body reacts to second-hand smoke comprise a mystery scientists are only beginning to unravel... 24 Aug 2010 at 5:00pm The SUN 1087 trial of Stutent (sunitinib malate) combined with erlotinib versus just elrotinib did not improve overall survival in patients with previously treated NSCLC (non-small cell lung cancer), Pfizer Inc. informs. However, the combination therapy did demonstrate a significant improvement in progression free survival.... 24 Aug 2010 at 3:00am Pfizer Inc. (NYSE :PFE) announced that the SUN 1087 trial of sunitinib in combination with erlotinib versus erlotinib demonstrated a statistically significant improvement in Progression-Free but not in Overall Survival in patients with previously treated advanced non-small cell lung cancer (NSCLC)... 21 Aug 2010 at 4:00am ArQule, Inc. (Nasdaq: ARQL) and Daiichi Sankyo Co., Ltd. (TSE 4568) announced that they will move forward with a Phase 3 clinical trial of ARQ 197, a small molecule inhibitor of the c-Met receptor tyrosine kinase, in patients with non-small cell lung cancer (NSCLC). In connection with this decision, the sponsor company, Daiichi Sankyo, will file a Special Protocol Assessment (SPA) with the U.S... 20 Aug 2010 at 3:00am ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops antibody-based targeted anticancer products, today announced that the US Food and Drug Administration (FDA) has granted orphan drug designation to its lorvotuzumab mertansine (formerly IMGN901) product candidate when used for the treatment of small-cell lung cancer (SCLC)... 19 Aug 2010 at 3:00am Patients with advanced lung cancer who received integrated palliative care early on during treatment had a better quality of life and survived for two months longer compared to patients receiving standard care only, according to a study published in the August 19th issue of NEJM (New England Journal of Medicine)... 19 Aug 2010 at 2:00am Adult stem cells that are vital for airway repair in the lung but that persist in areas where pre-cancerous lesions are found are associated with a poor prognosis in patients who develop cancer, even those with early stage disease, researchers at UCLA's Jonsson Comprehensive Cancer Center have found... 19 Aug 2010 at 2:00am One of the most tantalizing developments in anti-cancer therapy over recent years has been the advent of targeted treatments, which have proven highly effective in holding aggressive cancers at bay in certain patients, although typically only for a limited period of time. A team led by Raffaella Sordella, Ph.D... |
6 Jan 2009 at 8:46pm Nicotine gum has been in use for over 20 years to help smokers quit abruptly yet close to two-thirds of smokers report that they would prefer to quit gradually. Scientists from the University of Pittsburgh and GlaxoSmithKline Consumer Healthcare have now observed that smokers who are trying to quit gradually can also be helped by nicotine gum. The results of the first study to test the efficacy and safety of using nicotine gum to assist cessation by gradual reduction are reported in the February 2009 issue of the American Journal of Preventive Medicine.......6 Jan 2009 at 8:46pm  Cancer and cell biology experts at the University of Cincinnati (UC) have identified a new tumor suppressor that may help researchers develop more targeted drug therapies to combat lung cancer. The study, led by Jorge Moscat, PhD, appears in the January 2009 issue of Molecular and Cellular Biology. Proto-oncogenes are genes that play a role in normal cell growth (turnover of cells and tissue) but, when genetically modified, can cause the out-of-control cell division that leads to cancer. Prior research had established that Ras, a proto-oncogene, is abnormally expressed in up to 25 percent of human lung cancers; however, scientists did not understand the specific cellular events by which abnormal Ras expression leads to transformation........6 Jan 2009 at 8:46pm  While examining patterns of DNA modification in lung cancer, a team of international scientists has discovered what they say is a surprising new mechanism. They say that "silencing" of a single gene in lung cancer led to a general impairment in genome-wide changes in cells, contributing to cancer development and progression........6 Jan 2009 at 8:46pm  New research in an animal model suggests that a diet high in inorganic phosphates, which are found in a variety of processed foods including meats, cheeses, beverages, and bakery products, might speed growth of lung cancer tumors and may even contribute to the development of those tumors in individuals predisposed to the disease........6 Jan 2009 at 8:46pm  Individuals with particular variants of certain genes involved in metabolizing the most potent carcinogen found in cigarette smoke have an increased risk of developing lung cancer. That is the conclusion of a new study reported in the February 1, 2009 issue of CANCER, a peer-evaluated journal of the American Cancer Society. The study's results may help shed light on how lung cancer develops and could have important implications for preventing smoking-related cancers........6 Jan 2009 at 8:46pm  Canadian scientists are trying to answer why some smokers develop lung cancer while others remain disease free, despite similar changes in lifestyle. Results were presented at the American Association for Cancer Research's Seventh Annual International Conference on Frontiers in Cancer Prevention Research........6 Jan 2009 at 8:46pm  Patients treated for locally advanced non-small cell lung cancer who receive chemotherapy and proton beam treatment have fewer instances of bone marrow toxicity than patients who receive the standard therapy of intensity-modulated radiation (IMRT) and concurrent chemotherapy, as per scientists from The University of Texas M. D. Anderson Cancer Center........6 Jan 2009 at 8:46pm  Patients operated on by surgeons who do not routinely remove cancer from the lungs may be at a higher risk for complications, as per a research studyconducted by scientists at Duke University Medical Center. "Our study observed that hospitals that do higher volumes of these types of surgeries have correspondingly lower mortality rates than those who do fewer of the procedures," said Andrew Shaw, M.D., an anesthesiologist at Duke and lead investigator on the study........6 Jan 2009 at 8:46pm  Oncologists at the Moores Cancer Center at the University of California, San Diego (UCSD) in La Jolla are hoping to stave off the relentless march of advanced lung cancer by treating patients with a novel kind of cancer vaccine. While a number of vaccines attempt to pump up the immune system to fight off a cancer, the new vaccine, Lucanix, is genetically engineered to also trick the cancer into turning off its immune system-suppressing activities........6 Jan 2009 at 8:46pm  For decades now, cigarette makers have marketed so-called light cigarettes which contain less nicotine than regular smokes with the implication that they are less harmful to smokers' health. A new UCLA study shows, however, that they deliver nearly as much nicotine to the brain. Reporting in the current online edition of the International Journal of Neuropsychopharmacology, UCLA psychiatry professor Dr. Arthur L. Brody and his colleagues observed that low-nicotine cigarettes act similarly to regular cigarettes, occupying a significant percentage of the brain's nicotine receptors........6 Jan 2009 at 8:46pm  In a small study of 20 audiorecorded interactions, physicians seldom responded empathetically to concerns raised by lung cancer patients, as per a report in the September 22 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. "Empathy is an important element of effective communication between patients and physicians and is linked to improved patient satisfaction and compliance with recommended therapy," the authors write as background information in the article. "Patients who are more satisfied with the communication in their medical encounters have improved understanding of their condition, with less anxiety and improved mental functioning." However, responding to patients' emotional needs can be challenging for physicians; they may begin medical school with empathy for their patients but gradually learn detachment, perhaps in order to cope with time constraints or sadness........6 Jan 2009 at 8:46pm  Pazopanib, a new oral angiogenesis inhibitor, has demonstrated interesting activity in difficult to treat non-small-cell lung cancer, US scientists report. In a phase II trial, 30 out of 35 patients treated with preoperative pazopanib for a minimum of two weeks saw their tumor size shrink by up to 85%........6 Jan 2009 at 8:46pm  Mayo Clinic scientists have observed that carrying a common genetic disorder doubles the risk of developing lung cancer in smokers and nonsmokers. The study is reported in the May 26 issue of the Archives of Internal Medicine, a journal published by the American Medical Association. Scientists observed that the genetic disorder, alpha-1 antitrypsin deficiency (1ATD), could explain up to about 12 percent of patients with lung cancer in this study and likely represents the same widespread risk in the general population. "This is a seriously underdiagnosed disorder and suggests that people who have lung cancer and chronic obstructive pulmonary diseases (COPD) in their families should be screened for these gene carriers," says Ping Yang, M.D., Ph.D., a Mayo Clinic epidemiologist and lead investigator on the study........6 Jan 2009 at 8:46pm  The first U.S. clinical trial using genetic screening to identify lung tumors likely to respond to targeted therapies supports the use of those drugs as first-line therapy rather than after standard chemotherapy has failed. While the study led by Massachusetts General Hospital Cancer Center researchers observed that upfront gefitinib (Iressa) therapy considerably improved the outcomes for non-small-cell-lung-cancer (NSCLC), additional research is mandatory before such a strategy can be used for routine therapy planning. The report appears in the May 20 Journal of Clinical Oncology........6 Jan 2009 at 8:46pm  Cells lining the mouth reflect the molecular damage that smoking does to the lining of the lungs, scientists at The University of Texas M. D. Anderson Cancer Center report today at the annual meeting of the American Association for Cancer Research. Examining oral tissue lining the mouth to gauge cancer-inducing molecular alterations in the lungs could spare patients and those at risk of lung cancer from more invasive, uncomfortable procedures used now, said senior researcher Li Mao, M.D., professor in M. D. Anderson's Department of Thoracic/Head and Neck Medical Oncology........4 Nov 2008 at 10:56pm  Vitamin D is essential to good health but needs to be activated to function properly in the human body. Until recently, this activation was thought to happen primarily in the kidneys, but a new University of Iowa study finds that the activation step can also occur in lung airway cells. The study also links the vitamin D locally produced in the lung airway cells to activation of two genes that help fight infection. The study results appear in the Nov. 15 issue of the Journal of Immunology, now online........4 Nov 2008 at 10:56pm  Individuals who take cholesterol-lowering statins before being hospitalized with pneumonia appear less likely to die within 90 days afterward, as per a report in the October 27 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. In the United States and Europe, pneumonia hospitalization rates have increased 20 percent to 50 percent over the past decade, as per background information in the article. About 10 percent to 15 percent of those with pneumonia die from the disease. A recent review article indicated that statins may benefit patients with sepsis (infection of the bloodstream) or bacteremia (presence of bacteria in the bloodstream), possibly due to the medications' anti-clotting, anti-inflammatory or immune-modifying properties........4 Nov 2008 at 10:56pm  Patients in the Valley with emphysema might soon be breathing a little easier thanks to a new airway bypass study called the Exhale Airways Stents for Emphysema (EASE) trial. The trial principal is Dr. Karl Van Gundy aided by researchers Drs. Michael Peterson, Jose Joseph, Timothy Evans and Kathryn Bilello all pulmonologists at UCSF Fresno Medical Education Program. The study is a multi-center, international trial that is designed to evaluate the safety and effectiveness of this new and innovative procedure. There are only two other sites administering the trial in California besides UCSF Fresno UC Davis Medical Center and Cedars-Sinai Medical Center in Los Angeles........4 Nov 2008 at 10:56pm  Sleep-disordered breathing (also known as sleep apnea) is linked to an increased risk of death, as per new results from the Wisconsin Sleep Cohort, an 18-year observational study supported by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health. Scientists observed that adults (ages 30 to 60) with sleep-disordered breathing at the start of the study were two to three times more likely to die from any cause in comparison to those who did not have sleep-disordered breathing. The risk of death was associated with the severity of sleep-disordered breathing and was not attributable to age, gender, body mass index (an indicator of overweight or obesity), or cardiovascular health status........4 Nov 2008 at 10:56pm  Men who come to the hospital with pneumonia generally are sicker than women and have a higher risk of dying over the next year, despite aggressive medical care, as per a research studybeing presented Tuesday, May 20, at the 104th International Conference of the American Thoracic Society. Scientific sessions are scheduled May 16 to 21 in Toronto........4 Nov 2008 at 10:56pm  Scientists at Washington University School of Medicine in St. Louis have defined a new type of immune response that is activated in patients with severe asthma and COPD (chronic obstructive pulmonary disease). Their discovery could dramatically improve diagnosis and therapy of patients with chronic inflammatory lung disease........4 Nov 2008 at 10:56pm  Dry airways may not only play a central role in the development of the in-herited lung disease cystic fibrosis, but also in much more common ac-quired chronic lung diseases such as asthma and smoker's lung, the ciga-rette smoke-induced chronic obstructive pulmonary disease (COPD). This is the conclusion reached by researchers at Heidelberg University Hospital under the direction of Assistant Professor Dr. Marcus Mall from the Department of Pediatrics at Heidelberg University Hospital and Professor Dr. Richard Boucher of the University of North Carolina at Chapel Hill. In ani-mal studies, they observed that insufficient hydration of the airway surfaces leads to pathologies typical of chronic obstructive lung diseases in humans........4 Nov 2008 at 10:56pm  OHSU Smoking Cessation Center scientists outline key steps for developing and implementing clinic-based systems to provide smoking cessation therapy tailored to smokers with respiratory disorders. Smokers with lung disease require more than brief smoking cessation interventions to successfully quit, scientists in the Oregon Health and Science University Smoking Cessation Center report........4 Nov 2008 at 10:56pm  A single cannabis joint has the same effect on the lungs as smoking up to five cigarettes in one go, indicates research published ahead of print in the journal Thorax. The scientists base their findings on 339 adults up to the age of 70, selected from a research study that's ongoing of respiratory health, and categorised into four different groups........4 Nov 2008 at 10:56pm  Children of smokers who dont show any signs of respiratory problems may still be experiencing damaging changes in their airways that could lead to lung disease during the later part of life, as per a new study presented at the American Thoracic Society 2007 International Conference, on Sunday, May 20........4 Nov 2008 at 10:56pm  People with obstructive sleep apnea have a markedly increased risk of severe motor vehicle crashes involving personal injury, as per a research studypresented at the American Thoracic Society 2007 International Conference, on Sunday, May 20. The study of 800 people with sleep apnea and 800 without the nighttime breathing disorder observed that patients with sleep apnea were twice as likely as people without sleep apnea to have a car crash, and three to five times as likely to have a serious crash involving personal injury. Overall, the sleep apnea group had a total of 250 crashes over three years, compared with 123 crashes in the group without sleep apnea........4 Nov 2008 at 10:56pm  While working to find novel ways to treat the life-threatening disease of cystic fibrosis, scientists at the University of North Carolina have discovered that the rhythmic motion of the lungs during normal breathing is a critical regulator of the clearance of bacteria and other noxious materials. Their research, funded by the Cystic Fibrosis Foundation and the National Institute of Health, is reported in the latest issue of The Journal of Physiology........4 Nov 2008 at 10:56pm  Increased usual alcohol consumption among men is linked to an increased risk of a mild or worse sleep-related breathing disorder (SRBD), as per a research studyreported in the April 15th issue of the Journal of Clinical Sleep Medicine (JCSM). The study, authored by Paul E. Peppard, PhD, and his colleagues at the University of Wisconsin-Madison, focused on 775 men and 645 women, who were reviewed for alcohol consumption and a sleep-related breathing disorder. It was discovered that, relative to men who consumed less alcohol, for each increment of one drink per day, men who consumed more alcohol had 25 percent greater odds of a mild or worse SRBD........4 Nov 2008 at 10:56pm  Patients admitted to a hospital's intensive care unit (ICU) already are seriously ill, so the last thing they need is a new infection. Unfortunately, statistics show that as a number of as 25 percent of all patients admitted to the ICU and placed on ventilators develop pneumonia, which can be fatal........4 Nov 2008 at 10:56pm  Going to church might help you breathe easier. A new study by Temple Universitys Joanna Maselko, Sc.D., observed that religious activity may protect and maintain pulmonary health in the elderly. Pulmonary function is an important indicator of respiratory and overall health, yet little is known about the psychosocial factors that might predict pulmonary function. At the same time, religious activity is emerging as a potential health promoting factor, particularly among the elderly. We wanted to determine whether there was a correlation between the two, Maselko said........ |
1 Sep 2010 at 4:00am Adding a variety of vegetables to one's diet may help decrease the chance of getting lung cancer, and adding a variety of fruits and vegetables may decrease the risk of squamous cell lung cancer, especially among smokers. 31 Aug 2010 at 11:00pm Lung cancer is the leading cause of cancer deaths worldwide, and the prognosis is generally poor, even if surgery is successful. Furthermore, the incidence of one type of lung cancer, adenocarcinoma, has been increasing in recent years. 31 Aug 2010 at 11:00pm Chemotherapy is the best broad defense against cancer recurrence after surgical resection. However, it is difficult to predict which patients will benefit from which regimen of anticancer drugs, if at all. Building on existing knowledge, a new study has analyzed the usefulness of adjuvant chemotherapy for non-small cell lung cancer based on the histoculture drug response assay. 27 Aug 2010 at 10:00am Secondhand smoke is associated with a number of diseases and conditions, including cancer, heart disease and emphysema. It is an irritant to lung tissue and blood vessels, but the processes through which the body reacts to second-hand smoke is a mystery scientists are beginning to unravel. Researchers are now studying how second-hand smoke affects the lungs of rats. So far it appears that second-hand smoke triggers a complex inflammatory response. 23 Aug 2010 at 4:00pm Researchers have developed a nano-sized vehicle that can deliver chemotherapy drugs directly into cancer cells while avoiding interaction with healthy cells. The vehicle is very similar to a 'cluster bomb' and can be used to treat many different types of tumors, including lung, blood, colon and brain cancers. 20 Aug 2010 at 4:00pm Casual smokers may think that smoking a few cigarettes a week is "no big deal." But according to new research, having an infrequent smoke, or being exposed to secondhand smoke, may be doing more harm than people may think. The findings may further support public smoking bans, say the authors. 17 Aug 2010 at 4:00pm Adult stem cells that are vital for airway repair in the lung but that persist in areas where pre-cancerous lesions are found are associated with a poor prognosis in patients who develop cancer, even those with early stage disease, researchers have found. 17 Aug 2010 at 1:00am Researchers in Sweden have identified 12 genes that could be associated with aggressive breast tumors. The discovery could result in more reliable prognoses and better treatment strategies for patients. 16 Aug 2010 at 11:00pm One of the most tantalizing developments in anti-cancer therapy over recent years has been the advent of targeted treatments, which have proven highly effective in holding aggressive cancers at bay in certain patients, although typically only for a limited period of time. Now scientists have discovered new ways in which tumor cells develop resistance to one of the most successful targeted therapies, the small-molecule drug Tarceva (erlotinib). 16 Aug 2010 at 4:00am Clinical trials using patients' own immune cells to target tumors have yielded promising results. However, this approach usually works only if the patients also receive large doses of drugs designed to help immune cells multiply rapidly, and those drugs have life-threatening side effects. Now engineers have devised a way to deliver the necessary drugs by smuggling them on the backs of the cells sent in to fight the tumor. That way, the drugs reach only their intended targets, greatly reducing the risk to the patient. 13 Aug 2010 at 7:00am The identification of an oncogene specific to lung squamous cell carcinoma suggests that genetic activation of this oncogene could be used as an identification marker for this type of lung cancer. 12 Aug 2010 at 11:00pm Use of estrogen alone did not increase lung cancer mortality in postmenopausal women, according to a new study. 3 Aug 2010 at 4:00am With the growing number of long-term lung cancer survivors, research is needed to identify and address cancer survivorship issues. One of the most common and debilitating symptoms among lung cancer patients is dyspnea, or shortness of breath. As most studies of dyspnea have reviewed patients with active lung cancer or immediately after treatment, the prevalence of dyspnea over the long-term once treatment has been completed is not well characterized. 1 Aug 2010 at 11:00pm In patients with non-small cell lung cancer, five-year disease-free survival is currently the benchmark of cure. However, there are two issues that remain with the follow-up standards: when can cure be declared with confidence and for how long should follow-up examination be continued? 29 Jul 2010 at 11:00pm A research team from China investigated the effect of galangin on hepatocellular carcinoma (HCC) cells. They found that galangin mediates apoptosis through a mitochondrial pathway, and may be a potential chemotherapeutic drug for the treatment of HCC. |
|
All information in this site is deemed reliable but not guaranteed. Garypedia.com web site owner shall
not be responsible for any typographical errors, misinformation, and misprints and shall be held totally harmless individually.Garypedia.com is an independent provider of links to news articles. Garypedia.com contains links to sites on the internet which are owned and operated by the "External Sites". Garypedia.com is not responsible for the availability of any External Sites. Contact the site administrator or Webmaster for those External Sites if you have any concerns regarding such links or the links located on such External Sites. Garypedia.com is entirely committed to protecting the privacy of its mediapartners and their users. We use a browser feature known as a cookie. One way our cookies are useful is that they help to improve and personalize your experience by increasing a page's responsiveness and decreasing time between downloading as you browse or surf through the site. Additionally, a pixel tag is delivered with the newsfeeds themselves to organize information about online activity as a means to create anonymous profiles that reflect content preferences. No personally identifiable information is stored or collected. Any suggestions, please email us.
Copyright © 2007 Garypedia.com. All rights reserved. |
lung+cancer